Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
How to treat tumefactive demyelinating disease?
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
[Marihuana and cannobinoids as medicaments].
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Simvastatin regulates oligodendroglial process dynamics and survival.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
CD8-mediated inflammatory central nervous system disorders.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Epstein-Barr virus cause of multiple sclerosis.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Tysabri screening test may be unreliable
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
Vitamin D and multiple sclerosis: where do we go from here?
Coping strategies and mood profiles in patients with multiple sclerosis.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.

Pages